| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4afbca791bf772750c94f0d170f93b42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 |
| filingDate |
2013-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5350f7c3d871edd27f6a1d09bb5aeb3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea1cb5bd720328531eef969c0f6b87eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e295944391ab7c9250ec0c86536b2457 |
| publicationDate |
2015-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2921176-A2 |
| titleOfInvention |
Pharmaceutical composition for treatment of prostatic hyperplasia |
| abstract |
This invention relates to medicine and concerns a pharmaceutical composition containing the peptides Ala-Asp-Glu, Lys-Asp-Glu and Asp-Glu-Gly active in relation to benign prostatic hyperplasia, its application for treatment of benign prostatic hyperplasia, and the method of treating benign prostatic hyperplasia. The composition possesses a pronounced effect that is significantly superior to that of ± 1 -adrenergic blockers and inhibitors of 5 ±-reductase. The discovered effect makes it possible to use the pharmaceutical composition containing the peptides Ala-Asp-Glu, Lys-Asp-Glu and Asp-Glu-Gly to treat benign prostatic hyperplasia. |
| priorityDate |
2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |